摘要
目的探讨尿多酸肽(CDA-Ⅱ)单独和联合环腺苷酸(cAMP)对维甲酸耐药的急性早幼粒细胞白血病(APL)细胞的作用。方法以维甲酸耐药的APL细胞株NIM—R2为体外模型,观察使用CDA—Ⅱ单独和联合cAMP处理前后细胞生长和形态的改变;同时利用流式细胞术检测细胞的凋亡特征,包括细胞内DNA含量的分布、亚二倍体(sub—G1)细胞群所占比例、凋亡相关蛋白Bcl-2的表达水平等;并通过电泳鉴定因基因组DNA非随机性降解导致的梯状DNA。结果CDA-Ⅱ可以通过降低细胞内抗凋亡蛋白Bcl-2的水平,诱导NB4-R2细胞发生凋亡;cAMP则能显著加强CDA—Ⅱ的这一促凋亡作用1g/LCDA-Ⅱ联合100μmol/LcAMP共同处理NB4-R2细胞48h和72h时Bcl-2阳性细胞比例分别下降至(15.1±4.8)%和(7.3±2.9)%。100μmol/L cAMP单独作用可使MB4-R2细胞的Bcl-2阳性率由(92.0±0.6)%下降至(75.3±2.0)%。结论尿多酸肽CDA—Ⅱ联合cAMP对于维甲酸耐药的APL细胞株具有强烈的诱导凋亡效应。
Objective To investigate the effects of CDA- Ⅱ alone or combined with cAMP on the retinoic acid (RA)-resistant acute promyelocytic leukemia (APL) cells. Methods The RA-resistant cell line NB4-R2 was used as an in vitro model and treated with CDA- Ⅱ alone or in combination with cAMP. Cell apoptosis was assessed by morphology observation, distribution of cellular DNA contents and sab-G1 cell population. The level of Bcl-2 was detected by flow cytometry, DNA "ladder" was detected by agarose-electrophoresis. Results CDA- Ⅱ could induce NB4-R2 cell apoptosis through decreasing the level of cellular anti-apoptotic protein Bcl-2. cAMP could significantly enhance the role of CDA- Ⅱ. Bcl-2 positive cell rates decreased to (15.1±4.8)% and (7.3 ±2.9)% in NB4-R2 cells treated with 1 mg/ml CDA-Ⅱ plus 100 μmol/L cAMP for 48 h and 72 h, respectively. While 100 μmol/L of cAMP could decrease Bcl-2 positive NB4-R2 cells from (92.0± 0.6) % to (75.3 ± 2.0) %. Conclusions CDA-Ⅱ combined with cAMP could exert potent apoptotic effect on RA-resistant APL cells.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2008年第9期603-606,共4页
Chinese Journal of Hematology
基金
国家自然科学基金(30570778、30670882)
国家973计划(2002CB512805)
国家863计划(2006AA02Z19A)
上海市教委曙光计划
上海交通大学医学骨干师资计划
关键词
尿多酸肽
环腺苷酸
维甲酸耐药
细胞凋亡
CDA-Ⅱ
cAMP (cyclic AMP)
Resistance, retinoic acid
Cell apoptosis